Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
synthetic biology
Biotech
Merck bets up to $1B on Pearl's 'smart' biologics
Pearl Bio has signed onto a major licensing deal with Merck while raising its own series A round.
Max Bayer
Mar 12, 2024 8:00am
Ginkgo, Google Cloud ink AI tie-up with eyes on protein modeling
Aug 29, 2023 10:35am
Synthetic sticky molecules could bind cells and build organs
Dec 13, 2022 9:29am
'Programmable molecular scissors' to snip COVID-causing virus
Nov 18, 2022 8:50am
7 months after biotech pivot, Zymergen is acquired by Ginkgo
Jul 25, 2022 9:00am
Octant closes $80M funding, nabs new leaders
Apr 21, 2022 8:30am